Tekla Life Sciences Investors (HQL) |
|
15.07 0.51 (3.5%)
|
05-18 02:48 |
|
Open: |
14.67 |
Pre. Close: |
14.56 |
|
High:
|
15.07 |
Low:
|
14.67 |
|
Volume:
|
72,998 |
Market Cap:
|
379(M) |
|
|
|
|
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. It was formerly known as H&Q Life Sciences Investors fund. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
15.09 - 15.15 |
15.15 - 15.22 |
|
Low:
|
14.55 - 14.61 |
14.61 - 14.68 |
|
Close:
|
14.97 - 15.08 |
15.08 - 15.19 |
|
Technical analysis |
as of: 2022-05-17 4:47:41 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 18.55 One year: 19.99 |
| Support: |
Support1: 13.88 Support2: 11.54 |
| Resistance: |
Resistance1: 15.88 Resistance2: 17.12 |
| Pivot: |
15.07  |
| Moving Average: |
MA(5): 14.45  MA(20): 15.43
MA(100): 16.94 MA(250): 19.24 |
| MACD: |
MACD(12,26): -0.6 Signal(9): -0.5 |
| Stochastic oscillator: |
%K(14,3): 32.6 %D(3): 19.9 |
| RSI: |
RSI(14): 44.4 |
| 52-week: |
High: 22.7 Low: 13.88 |
| Average Vol(K): |
3-Month: 75 (K) 10-Days: 92 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ HQL ] has closed above bottom band by 49.7%. Bollinger Bands are 60.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 6 days. This is a sign that the current trend might continue. |
|
|
Headline News |
Tue, 17 May 2022
Tekla Life Sciences Investors Declares Distribution | Business | valdostadailytimes.com - Valdosta Daily Times
Thu, 12 May 2022
Short Interest in Tekla Life Sciences Investors (NYSE:HQL) Grows By 262.8% - Defense World
Mon, 09 May 2022
GRX: Not Among The Best Closed-End Healthcare-Based Funds - Seeking Alpha
Wed, 04 May 2022
THW: Continues To Be A Safe Bet For Income Seeking Investors - Seeking Alpha
Wed, 27 Apr 2022
HQL: Buy For The Yield, If You Can Stomach The Depreciation - Seeking Alpha
Mon, 25 Apr 2022
Hibernate ORM 6.0 Delivers Improved Performance - InfoQ.com
|
Financial Analysis |
| Price to Book Value: |
Neutral |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Neutral |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Neutral |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NYSE |
| Sector: Financial Services |
| Industry: Asset Management |
| Shares Out. |
0 (M) |
| Shares Float |
25 (M) |
|
% Held by Insiders
|
0 (%) |
|
% Held by Institutions
|
0 (%) |
|
Shares Short
|
41 (K) |
|
Shares Short P.Month
|
0 (K) |
Stock Financials |
|
EPS
|
0 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
-65.6 |
|
Profit Margin (%)
|
2 |
|
Operating Margin (%)
|
822.5 |
|
Return on Assets (ttm)
|
-181.1 |
|
Return on Equity (ttm)
|
-0.6 |
|
Qtrly Rev. Growth
|
2.29e+006 |
|
Gross Profit (p.s.)
|
-3.15 |
|
Sales Per Share
|
14.4 |
|
EBITDA (p.s.)
|
2.57303e+006 |
|
Qtrly Earnings Growth
|
2.6 |
|
Operating Cash Flow
|
0 (M) |
|
Levered Free Cash Flow
|
0 (M) |
Stock Valuations |
|
PE Ratio
|
0 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
-0.23 |
|
Price to Sales
|
1.04 |
|
Price to Cash Flow
|
0.63 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
17960 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
2018-12-30 |
|
Ex-Dividend Date
|
2021-11-22 |
|
7 Binary Options
|
|
Your Ad Here
|
|
